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Research
Findings in cohort and time-series studies
suggest that environmental exposure to
particulate matter (PM) air pollution is asso-
ciated with increases in cardiovascular hospi-
talization and mortality (Pope and Dockery
2006). Individuals at greatest risk have
included elderly individuals with preexisting
cardiovascular disease or other illnesses such
as diabetes that place them at high risk for
myocardial infarction or stroke.
Pathophysiologic mechanisms underlying
the epidemiologic studies have been proposed
and are under investigation (Utell et al.
2002). It is relevant in this regard that cohort
studies have found that risk of cardiovascular
events, including myocardial infarction, is
associated with increased blood levels of
inﬂammatory cytokines such as interleukin-6
(IL-6), tumor necrosis factor-α (TNF-α) and
its receptors, adhesion molecules, and acute-
phase proteins such as C-reactive protein
(CRP) and fibrinogen (Pai et al. 2004).
However, risk prediction based on these bio-
markers may be in large part secondary to
major modiﬁable environmental, behavioral,
and clinical risk factors that are likely driving
oxidative stress and inflammation (Folsom
et al. 2006).
Among the potential environmental risk
factors are air pollutants. It is possible, given
the mounting toxicologic evidence, that air
pollutant components may induce oxidative
stress and inflammatory and prothrombotic
responses by vascular endothelial cells, leuko-
cytes, and platelets, with expression of inﬂam-
matory cytokines, cellular adhesion molecules,
and coagulation factors (Mills et al. 2007). To
clarify the relevance of these emerging experi-
mental data, biomarker response data are
needed in human subjects at increased cardio-
vascular risk.
In addition, the causal pollutant compo-
nents driving the relationship of cardiovascu-
lar morbidity and mortality with PM remain
to be identiﬁed. Historically, the difﬁculty in
epidemiologic studies has been that the only
available air pollution data originated from
central regional ambient sites, which may not
be representative of personal exposures, result-
ing in imprecise associations. Furthermore,
the importance of particle size and chemistry
has been limited by reliance on particle mass
concentrations at two size cuts, PM10 (PM
≤ 10 µm in aerodynamic diameter) and PM2.5
(PM ≤ 2.5 µm). However, for the last several
years, there has been mounting experimental
evidence that ultraﬁne particles (UFPs; tenta-
tively defined as PM < 0.1 µm in diameter)
can induce the greatest amount of oxidative
stress and inﬂammation per unit of PM mass
(Cho et al. 2005; Ntziachristos et al. 2007).
UFPs have high pulmonary deposition effi-
ciency and particle number (PN) concentra-
tions magnitudes higher than those for larger
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BACKGROUND: Biomarkers of systemic inﬂammation have been associated with risk of cardiovascular
morbidity and mortality.
OBJECTIVES: We aimed to clarify associations of particulate matter (PM) air pollution with systemic
inﬂammation using models based on size-fractionated PM mass and markers of primary and sec-
ondary aerosols.
METHODS: We followed a panel of 29 nonsmoking elderly subjects with a history of coronary artery
disease (CAD) living in retirement communities in the Los Angeles, California, air basin. Blood
plasma biomarkers were measured weekly over 12 weeks and included C-reactive protein (CRP), ﬁb-
rinogen, tumor necrosis factor-α (TNF-α) and its soluble receptor-II (sTNF-RII), interleukin-6
(IL-6) and its soluble receptor (IL-6sR), ﬁbrin D-dimer, soluble platelet selectin (sP-selectin), soluble
vascular cell adhesion molecule-1 (sVCAM-1), intracellular adhesion molecule-1 (sICAM-1), and
myeloperoxidase (MPO). To assess changes in antioxidant capacity, we assayed erythrocyte lysates
for glutathione peroxidase-1 (GPx-1) and copper-zinc superoxide dismutase (Cu,Zn-SOD) activities.
We measured indoor and outdoor home daily size-fractionated PM mass, and hourly pollutant gases,
total particle number (PN), ﬁne PM elemental carbon (EC) and organic carbon (OC), estimated sec-
ondary organic aerosol (SOA) and primary OC (OCpri) from total OC, and black carbon (BC). We
analyzed data with mixed models controlling for temperature and excluding weeks with infections.
RESULTS: We found signiﬁcant positive associations for CRP, IL-6, sTNF-RII, and sP-selectin with
outdoor and/or indoor concentrations of quasi-ultraﬁne PM ≤ 0.25 µm in diameter, EC, OCpri,
BC, PN, carbon monoxide, and nitrogen dioxide from the current-day and multiday averages. We
found consistent positive but largely nonsignificant coefficients for TNF-α, sVCAM-1, and
sICAM-1, but not ﬁbrinogen, IL-6sR, or D-dimer. We found inverse associations for erythrocyte
Cu,Zn-SOD with these pollutants and other PM size fractions (0.25–2.5 and 2.5–10 µm). Inverse
associations of GPx-1 and MPO with pollutants were largely nonsigniﬁcant. Indoor associations
were often stronger for estimated indoor EC, OCpri, and PN of outdoor origin than for uncharac-
terized indoor measurements. There was no evidence for positive associations with SOA.
CONCLUSIONS: Results suggest that trafﬁc emission sources of OCpri and quasi-ultraﬁne particles
lead to increased systemic inﬂammation and platelet activation and decreased antioxidant enzyme
activity in elderly people with CAD.
KEY WORDS: acute-phase proteins, cytokines, enzymes, epidemiology, longitudinal data analysis,
oxidative stress, panel study, particulate air pollution. Environ Health Perspect 116:898–906
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face area. This large surface area carries high
concentrations of toxic air pollutants such as
polycyclic aromatic hydrocarbons (PAHs) and
transition metals shown to induce oxidative
stress responses (Li et al. 2003; Oberdörster
2001) and to translocate systemically from
pulmonary sites (Elder and Oberdörster
2006). UFPs are a key size fraction emitted or
formed close to sources of fossil fuel combus-
tion that, as a result, leads to greater spatial
variability than for larger size fractions.
Therefore, exposure assessments of UFPs near
the subject require special attention in epi-
demiologic research (Sioutas et al. 2005).
Epidemiologic studies have shown that expo-
sure markers for primary products of fossil fuel
combustion point to important causal sources
behind associations of particle mass with car-
diovascular outcomes (Delﬁno et al. 2005).
We hypothesized that biomarkers of sys-
temic inflammatory responses will be posi-
tively associated with ultrafine PM mass,
total PN concentration, and markers of pri-
mary combustion-related organic compounds
from sources such as vehicular exhaust. We
further hypothesized that associations for
predicted indoor exposure to PM of outdoor
origin will be stronger than associations for
unadjusted (raw) indoor exposures. To test
these hypotheses, we conducted a study
involving 12 repeated measurements of air
pollutant exposures and circulating biomark-
ers of inﬂammation, antioxidant activity, and
platelet activation in subjects with coronary
artery disease (CAD) living in retirement com-
munities within the Los Angeles, California,
air basin. We collected air pollution data using
a broad array of air monitors both in the
immediate outdoor home environment and at
indoor sites of the retirement communities
studied. We took this approach to limit
personal exposure error and allow detailed
assessments of particle characteristics.
Materials and Methods
Design and population. In 2005–2006, we
studied residents in independent living facili-
ties of two retirement communities east of
downtown Los Angeles. We started weekly
follow-up with 33 subjects, but two subjects
withdrew early and two subjects had too
many infections (gastrointestinal and respira-
tory) to be included in the analysis, which
excludes such observations. Over 7-month
periods, we followed each subject with 12
weekly blood draws. We followed 18 and 13
subjects in the two retirement communities in
four alternating 6-week phases. In each com-
munity, we collected 6 weeks of data during a
warmer period of high photochemical activity
(July to mid-October) and 6 weeks of data
during a cooler period of higher air stagnation
(mid-October to February).
We recruited subjects after referral to the
study ofﬁce by retirement-community nurses,
or after self-referral through flyers and study
presentations. Inclusion criteria included age
≥ 65; history of CAD diagnosis, which could
include a history of myocardial infarction and
bypass surgery but not within the preceding
12 months; and being sufﬁciently ambulatory
to perform sit-to-stand transfers over short dis-
tances. Exclusion criteria included employment
outside of the monitored home, smoking
within the preceding 12 months, psychiatric
disorders, dementia, alcohol or drug abuse,
Parkinson or other debilitating neuromuscular
diseases, dialysis treatment, daily oral cortico-
steroids, or medical conditions that would
place the subject or staff at risk from the blood
donation. The Institutional Review Board of
the University of California, Irvine, approved
the study protocol. We obtained informed
written consent from all subjects.
Blood collection and analysis. We drew
venous peripheral blood samples at the same
time of day and day of week to control for
circadian rhythm and day-of-week effects. We
used chilled anticoagulant Vacutainer tubes
[ethylenediaminetetraacetic acid (EDTA) and
citrate theophylline adenosine dipyridamole
(CTAD) tubes]. Blood was rapidly separated
(< 30 min after blood draw) into erythrocytes
and plasma by using an onsite mobile field
laboratory to minimize ex vivo changes in bio-
markers. After centrifugation, each fraction
was aliquoted, coded, transported frozen on
dry ice from the field to our laboratory, and
stored at –80°C until tested.
We measured concentrations of the follow-
ing biomarkers in EDTA plasma using 96-well
immunoassay kits: acute-phase proteins (fib-
rinogen and high-sensitivity CRP; Zymutest;
Hyphen BioMed, Neuville-sur-Oise, France),
ﬁbrin D-dimer (marker of coagulation activa-
tion and fibrinolysis; Zymutest; Hyphen
BioMed), proinflammatory cytokines (IL-6
and TNF-α; Quantikine HS; R&D Systems,
Minneapolis, MN), soluble cytokine receptors
[IL-6 soluble receptor (IL-6sR) and TNF-α
soluble receptor II (sTNF-RII); Quantikine;
R&D Systems], and myeloperoxidase (MPO;
ALPCO Diagnostics, Salem, NH). MPO is
primarily an indicator of neutrophil activation
and is involved in the oxidative modiﬁcation of
lipoproteins. We analyzed soluble vascular cell
adhesion molecule-1 (sVCAM-1) and soluble
intracellular adhesion molecule-1 (sICAM-1)
in plasma from CTAD tubes using a Linco
Research Multiplex System (Linco Research,
St. Charles, MO). We quantified soluble
platelet selectin (sP-selectin), a marker of
platelet activation (Jurk and Kehrel 2005), in
CTAD-plasma by ELISA (R&D Systems). To
examine changes in antioxidant capacity, we
assayed erythrocyte lysates spectrophotometri-
cally for activities of glutathione peroxidase-1
(GPx-1) and copper-zinc superoxide dismutase
(Cu,Zn-SOD) using commercial test kits
(Cayman Chemical, Ann Arbor, MI). The
units of GPx-1 and Cu,Zn-SOD activities
were normalized to units per gram of hemoglo-
bin (Hb) in each sample (cyanmethemoglobin
method). All samples of the same individual
were analyzed in duplicate to ensure repro-
ducibility and on the same microtiter plate to
circumvent interassay variation.
Exposures. We made indoor and outdoor
home measurements of air pollutants and
weather variables in the immediate vicinity of
each retirement community. We measured
size-fractionated 24-hr mean mass concentra-
tions (µg/m3) of quasi-UFPs, 0–0.25 µm in
diameter (PM0.25); accumulation-mode parti-
cles, 0.25–2.5 µm in diameter (PM0.25–2.5);
and coarse mode particles, 2.5–10 µm in diam-
eter (PM2.5–10). Considering that the upper
size cut points traditionally used to define
ultrafine mode particles (0.10–0.18 µm) are
somewhat lower than the present cut point,
PM0.25 is referred to here as “quasi-ultraﬁne.”
We collected daily Teflon filter samples of
PM0.25, PM0.25–2.5, and PM2.5–10 over 5 days
(before the blood draw on Friday afternoons)
with a Sioutas Personal Cascade Impactor
Sampler using a 9 L/min pump (SKC, Inc.
Eighty Four, PA). We made all other air pol-
lutant measurements hourly for 9 days before
the blood draw.
Indoor and outdoor hourly particle mea-
surements included total PN concentration
(particles/cm3) using the Condensation
Particle Counter (model 3785; TSI, Inc.,
Shoreview, MN), and PM2.5 organic carbon
(OC) and PM2.5 elemental carbon (EC) using
two OC/EC analyzers (model 3F; Sunset
Laboratory Inc., Tigard, OR). Particulate OC
and EC were measured in hourly cycles (sam-
pling time, 45 min; analysis time, 15 min).
We placed a multichannel parallel carbon-
plate diffusion denuder upstream of the
OC/EC instrument to remove most of the
organic vapors in the sampled air. We used a
modiﬁed National Institute for Occupational
Safety and Health analysis protocol to evolve
particulate OC and EC. Elsewhere, we give a
detailed description of all quality control and
quality assurance analyses performed with the
OC/EC analyzer (Arhami et al. 2006; Polidori
et al. 2007). As an alternate measure of car-
bonaceous aerosols components, we measured
outdoor hourly black carbon (BC) with an
aethalometer (Magee Scientific, Berkeley,
CA). Using standard reference methods, we
measured hourly home pollutant gases,
including indoor and outdoor nitrogen diox-
ide and carbon monoxide, and outdoor ozone. 
We estimated concentrations of two gen-
eral types of OC. Primary OC (OCpri) is emit-
ted directly as products of incomplete
combustion (e.g., PAH) from sources such as
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organic aerosol (SOA) is formed when volatile
reactive organic gases and semivolatile species
(primarily aromatics in Los Angeles, but also
alkanes, and biogenic monoterpenes and
olefins) are oxidized to form low-volatility
products that condense to produce organic
PM (Manchester-Neesvig et al. 2003;
Robinson et al. 2007). The contributions of
OCpri and SOA to measured outdoor OC
were estimated from collected OC and EC
concentrations using EC as a tracer of primary
combustion-generated OC (i.e., “EC tracer
method”) (Cabada et al. 2004). As described
in detail by Polidori et al. (2007), this method
assumes that OCpri and EC are emitted from
the same combustion sources. Typically, esti-
mated SOA values were generally higher dur-
ing the afternoon hours of summertime
photochemical smog episodes.
Because our aim was to assess the effects
of outdoor air pollutants, the indoor pollu-
tants of interest are those of outdoor origin.
Therefore, we first estimated air exchange
rates and inﬁltration factors (Finf) at each site.
We used estimated Finf and measured particle
concentrations across all hours in a single-
compartment mass balance model to assess
the contributions of indoor and outdoor
sources to measured indoor EC, OCpri, SOA,
and PN (Polidori et al. 2007). Thus, we
determined the average amount of outdoor
PM that penetrated inside the studied homes
(outdoor-generated PM) by this approach.
We assume that indoor exposures to PM of
outdoor origin are relevant to personal expo-
sures given that people in the retirement com-
munities spend most of their time indoors.
Analysis. We analyzed relationships of cir-
culating biomarker concentrations to air pollu-
tant exposures using linear mixed-effects
models (Verbeke and Molenberghs 2001).
This allows each subject to serve as his or her
control over time (12 weekly measurements)
and controls for potential confounding from
between-subject covariates that do not change
over time. Because the within-individual
repeated measures of outcomes were correlated,
and similarly so for the phase of study and
retirement community, we assumed a two-
stage hierarchical model with random effects at
the subject level, nested within phase and com-
munity. We ﬁt an autoregressive-1 correlation
model given the covariance structure observed
from empirical variograms. We conducted
residual diagnostics to assess deviations from
assumed functional form, and the presence of
inﬂuential data points and subject clusters. Log
transformation of biomarkers that exhibited
skewed distribution (CRP, TNF-α, and
MPO) did not improve the ﬁt of the models or
qualitatively change our ﬁndings.
We tested models for the 24-hr average
period preceding the blood draw (exposure
lag 0) as well as cumulative exposures up to 9
days (or 5 days for particle mass) before the
blood draw to assess more acute versus cumula-
tive exposure–response relationships, respec-
tively. Data for exposure variables had to
include ≥ 75% of the relevant exposure period.
We investigated potential confounding by
weather variables. Temperature minimally
inﬂuenced effect estimates, and we retained it
in ﬁnal models (same averaging time as the air
pollutant). We decided a priori to adjust for
acute infectious illnesses by excluding weeks
with such observations given their known
marked inﬂuence on biomarkers of inﬂamma-
tion. Medication variables were relatively sta-
ble during the 12-week follow-up and of
more interest as effect modifiers. These
include use of 3-hydroxy-3-methylglutaryl
coenzyme A (HMG CoA) reductase inhibitors
(statins), and angiotensin-converting enzyme
(ACE) inhibitors or angiotensin II receptor
blockers (ARBs). Use of these medications
may dampen pollutant effects from their
known protective influences on oxidative
stress and inflammation. We tested a binary
(yes/no) indicator for use of these medications
and assumed that product term interactions
with a p-value < 0.1 suggested possible effect
modiﬁcation.
Results
Descriptive data. Descriptive characteristics
of the 29 subjects are shown in Table 1.
Descriptive data for the biomarker measure-
ments are shown in Table 2. We obtained 331
person-days of blood samples for biomarker
measurements without any report of infection in
the previous week (30 samples), ranging from
12 to 16 samples per week over the 24 weeks of
follow-up (12 weeks per community).
Spearman correlations between biomarkers
were strongest for IL-6 with TNF-α, sTNF-
RII, sICAM-1, CRP, and ﬁbrinogen (r range,
0.34–0.58) (not shown). Smaller correlations
were observed for IL-6 with sP-selectin and
sVCAM-1 (r range, 0.19–0.22) and among
sTNF-RII, sP-selectin, CRP, and ﬁbrinogen (r
range, 0.18–0.28, except CRP and ﬁbrinogen,
r = 0.43). The strongest correlations were
between IL-6 and CRP (r = 0.58) and between
sICAM-1 and sVCAM-1 (r = 0.48). Cu,Zn-
SOD was inversely correlated with sP-selectin
(r = –0.29) and IL-6sR (r = –0.27).
Descriptive statistics for exposures are
shown in Table 3. We previously identified
Delfino et al.
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Table 2. Biomarker concentrations (331 measurements).
Biomarkera Mean ± SD Median (Min–Max)
IL-6 (pg/mL) 2.95 ± 2.32 2.45 (0.28–20.14)
IL-6sR (ng/mL) 43.0 ± 13.9 40.8 (12.1–124)
TNF-α (pg/mL)b 1.82 ± 2 1.18 (0.5–14.3)
sTNF-RII (pg/mL) 3,933 ± 1,555 3,502 (658–11,584)
sP-selectin (ng/mL) 37.6 ± 15.1 36 (6–221)
sVCAM-1 (ng/mL) 787 ± 252 751 (203–1,639)
sICAM-1 (ng/mL) 155 ± 52 159 (74–383)
CRP (ng/mL)c 3,134 ± 3,796 1,938 (250–26,799)
Fibrinogen (µg/mL) 3,542 ± 1,200 3,299 (500–9,149)
D-dimer (ng/mL)d 820 ± 527 686 (250–3,366)
Cu,Zn-SOD (U/g Hb) 5,260 ± 1,671 5,018 (669–13,138)
GPx-1 (U/g Hb) 14.7 ± 5.6 14.2 (5.5–47)
MPO (ng/mL) 27.7 ± 30.7 17.6 (5–298)
Abbreviations: Max, maximum; Min, minimum.
aExcludes observations for weeks when there was a reported infection. bValues of TNF-α < 0.5 could not be measured
and were set to 0.5. cValues of CRP < 250 could not be measured and were set to 250. dValues of D-dimer < 250 could not
be measured and were set to 250.
Table 1. Characteristics of subjects.
Mean ± SD
Characteristic or no. (%)
Age (years) 85.7 ± 5.94






Myocardial infarction 10 (34.5)
Coronary artery bypass graft  10 (34.5)
or angioplasty
Positive angiogram or stress test 6 (20.7)
Clinical diagnosis 3 (10.3)
Current angina pectoris 9 (31.0)
Pacemaker or deﬁbrillator 8 (27.6)
Cardiac arrhythmia 11 (37.9)




Type II diabetes 5 (17.2)
COPD or asthma 4 (13.8)
Stroke or transient ischemic attack 5 (17.2)
Medications
ACE inhibitors and ARBs 15 (51.7)
HMG CoA reductase inhibitors (statins) 16 (55.2)
Platelet aggregation inhibitorsb 10 (34.5)
Aspirin 16 (55)
Calcium channel blockers 9 (31.0)
Smoking history
Never smoker 25 (86.2)
Ex-smoker (no smoking preceding 12 months) 4 (13.8)
Abbreviations: BMI, body mass index; COPD, chronic
obstructive pulmonary disease.
aEach category is hierarchical and excludes being in the
above diagnostic category. bThree were also taking
coumadin. indoor source contributions to PN and EC
from cooking in our analysis of indoor PM of
outdoor origin (Polidori et al. 2007), and this
may explain why PM0.25 was higher indoors
than outdoors. The relatively high outdoor
PM0.25 reflects freshly emitted aerosols from
local traffic sources of PM pollution in the
Los Angeles area. A correlation matrix for air
pollutants is shown in Supplemental Material,
Table 1 (Supplemental Material is available
online at http://www.ehponline.org/mem-
bers/2008/11189/suppl.pdf). Markers for
products of primary combustion were
strongly correlated with each other (EC, BC,
OCpri, PM0.25, NO2, and CO), whereas PN
concentrations were moderately correlated
with these pollutants. Indoor versus outdoor
PM0.25, and indoor versus outdoor PM0.25–2.5
were strongly correlated. O3 was inversely
correlated with PN and most of the markers
of primary combustion.
Regression analyses. Overview. We found
associations between several biomarkers and
hourly air pollutants for lag 0 out to 9-day
average concentrations. To simplify the pre-
sentation, we show models for lag 0 and for
multiday averages for 3 days (or 5 days) and 9
days before the blood draw. We also found
associations from lag 0 through the 4-day
average of the various size-fractionated parti-
cle mass measurements. To simplify the pre-
sentation, we show models for lag 0 and
4-day averages. Overall, we observed signifi-
cant (p < 0.05) associations for some but not
all biomarkers and pollutant averaging times.
The most significant positive associations
with air pollutants were for CRP, IL-6,
sTNF-RII, and sP-selectin (Figures 1–3). We
also found signiﬁcant inverse associations for
Cu,Zn-SOD with air pollutants (Figure 4).
Negative regression coefficients were also
found for GPx-1 and MPO, but most were
nonsignificant. Models for fibrinogen were
not consistent with models for CRP and were
mostly nonsigniﬁcant. Although most regres-
sion parameter estimates were positive, few
were significant for TNF-α, sVCAM-1, or
sICAM-1. Regression parameter estimates
were largely negative and nonsignificant for
the IL-6sR. Parameter estimates for ﬁbrin D-
dimer were close to zero for most models.
Data tables for Figures 1–4 (including addi-
tional multiday average exposures) and for
fibrinogen, TNF-α, sVCAM-1, sICAM-1,
IL-6 receptor, GPx-1, and MPO are available
in Supplemental Material, Tables 2–4
(Supplemental Material is available online at
http://www.ehponline.org/members/2008/
11189/suppl.pdf).
Biomarkers of inﬂammation (CRP, IL-6,
and sTNF-RII). Figure 1 shows the relation-
ships of outdoor air pollutant exposures with
these biomarkers. For size-fractionated parti-
cle mass data, outdoor quasi-ultraﬁne PM0.25
was positively associated with CRP, IL-6, and
sTNF-RII. There was an unexpected inverse
association of IL-6 and CRP with 4-day aver-
age outdoor accumulation-mode PM0.25–2.5.
We observed positive associations of CRP,
IL-6, and sTNF-RII with outdoor particulate
and gaseous markers of primary combustion
products (EC, BC, OCpri, NO2, CO) but not
with SOA or total OC. Outdoor PN was posi-
tively associated with these biomarkers, as
well. There was an unexpected inverse associa-
tion of CRP with SOA.
Figure 2 shows the relationships of indoor
air pollutant exposures with CRP, IL-6, and
sTNF-RII. Unlike the outdoor data, none of
the models for indoor particle mass was signiﬁ-
cant, and some parameters were negative. CRP
and IL-6 were somewhat more strongly associ-
ated with indoor EC of outdoor origin than
was uncharacterized indoor EC. CRP, IL-6,
and sTNF-RII were also positively associated
with indoor OCpri of outdoor origin, but not
total indoor OC or SOA of outdoor origin
(some estimates were negative for CRP). We
also observed stronger positive associations of
IL-6 with indoor PN of outdoor origin than
for uncharacterized indoor PN. Positive associ-
ations for indoor NO2 and CO were largely
consistent with ﬁndings for outdoor gases.
Biomarker of platelet activation
(sP-selectin). Figure 3A shows the relation-
ships of outdoor air pollutant exposures with
this biomarker. Outdoor coarse PM2.5–10 was
significantly associated with increased
sP-selectin. Five-day average outdoor PM0.25
was nearly signiﬁcant [2.95 ng/mL; 95% con-
fidence interval (CI), –0.19 to 6.09; not
shown]. We found signiﬁcant positive associa-
tions of sP-selectin with most markers of pri-
mary combustion (EC, BC, OCpri) but not
SOA. Only 9-day average total OC was nearly
signiﬁcant (p < 0.07).
Figure 3B shows the relationships of
indoor air pollutant exposures with sP-selectin.
Indoor PM0.25 and PM2.5–10 were positively
and significantly associated with sP-selectin.
We also observed stronger positive associations
of sP-selectin with indoor EC of outdoor ori-
gin than for uncharacterized indoor EC.
Indoor OCpri of outdoor origin was positively
associated with sP-selectin but not indoor SOA
or PN of outdoor origin. Nine-day average
total OC was signiﬁcantly positive.
Biomarker of antioxidant activity
(Cu,Zn-SOD). Models for Cu,Zn-SOD were
strongly influenced by three female subjects,
resulting in a substantial decrease in the mag-
nitude of regression parameter estimates.
Inﬂuence statistics reﬂected this. For markers
of primary combustion, these three subjects
showed significant positive associations,
whereas the remaining 26 showed signiﬁcant
inverse associations. For instance, for an
interquartile increase in EC 5-day average,
Cu,Zn-SOD increased by 2,678 U/g Hb in
the three subjects (95% CI, 1,244 to 4,113),
Biomarkers of systemic inflammation and air pollution
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Table 3. Descriptive statistics of daily air pollutant measurements.
Exposure (24-hr averages) No. (missing) Mean ± SD Median IQR Min–Max
Outdoor hourly PM 
EC (µg/m3) 166 (14) 1.61 ± 0.62 1.56 0.92 0.24–3.94
OC (µg/m3) 166 (14) 5.94 ± 2.11 5.58 2.79 2.51–13.60
BC (µg/m3) 179 (1) 2.00 ± 0.77 1.89 0.96 0.58–5.11
OCpri (µg/m3) 166 (14) 3.37 ± 1.21 3.21 1.63 0.99–7.11
Secondary OC (µg/m3) 166 (14) 2.49 ± 1.50 2.10 1.86 0–8.10
PN (particles/cm3) 152 (28) 16,043 ± 5,886 13,968 7,386 6,837–31,263
Outdoor hourly gases 
NO2 (ppb) 178 (2) 33.10 ± 9.64 32.22 13.87 11.22–59.83
CO (ppm) 169 (11) 0.71 ± 0.29 0.70 0.41 0.14–1.68
O3 (ppb) 176 (4) 33.22 ± 11.68 32.19 15.69 8.50–70.88
Indoor hourly PM 
EC (µg/m3) 148 (32) 1.31 ± 0.52 1.30 0.70 0.19–2.89
EC of outdoor origin (µg/m3) 158 (22) 1.11 ± 0.39 1.06 0.51 0.41–2.97
OC (µg/m3) 148 (32) 5.69 ± 1.51 5.60 1.96 2.34–10.79
OCpri of outdoor origin (µg/m3) 166 (14) 2.18 ± 0.82 2.15 1.07 0.32–5.21
Secondary OC of outdoor origin (µg/m3) 166 (14) 2.08 ± 1.26 1.75 1.45 0–6.87
PN (particles/cm3) 144 (36) 14,494 ± 6,770 12,341 7,337 1,016–43,027
PN of outdoor origin (particles/cm3) 124 (56) 10,108 ± 3,108 9,580 3,684 1,016–17,700
Indoor hourly gases
NO2 (ppb) 170 (10) 32.3 ± 8.5 32.0 11.0 12.5–53.5
CO (ppb) 174 (6) 0.78 ± 0.30 0.73 0.42 0.22–1.97
Outdoor PM mass
PM0.25 (µg/m3) 106 (14) 9.47 ± 2.97 9.4 4.2 3.31–18.75
PM0.25–2.5 (µg/m3) 115 (5) 13.53 ± 10.67 11.7 11.5 1.29–66.77
PM2.5–10 (µg/m3) 106 (14) 10.04 ± 4.07 9.9 5.9 1.76–22.38
Indoor PM mass
PM0.25 (µg/m3) 104 (16) 10.45 ± 6.77 9.5 4.5 1.42–69.86
PM0.25–2.5 (µg/m3) 107 (13) 7.36 ± 4.57 6.5 5.7 0.77–30.86
PM2.5–10 (µg/m3) 111 (9) 4.12 ± 4.76 2.8 3.5 0.12–37.63
Abbreviations: IQR, interquartile range; Max, maximum; Min, minimum.whereas in the remaining 27 it decreased by
571 U/g Hb (95% CI, –346, to –121). The
only size fraction with signiﬁcant positive asso-
ciations in the three subjects was PM0.25, with
similarly large increases of 2,794–4,881 U/g
Hb for interquartile increases in all averaging
times through the 5-day average (p < 0.005).
Figure 4A shows the relationships of out-
door air pollutant exposures with Cu,Zn-SOD,
excluding the three subjects. All PM size frac-
tions were inversely associated with Cu,Zn-
SOD (outdoor PM0.25 and PM0.25–2.5 were
statistically signiﬁcant). We found inverse asso-
ciations for outdoor particulate and gaseous
markers of primary combustion products (EC,
BC, OCpri, NO2, CO) but not SOA or total
OC. Negative regression coefficients for PN
were nonsigniﬁcant.
Figure 4B shows the relationships of
indoor air pollutant exposures with
Cu,Zn-SOD excluding the three subjects.
Indoor particle mass associations were consis-
tent with findings for outdoor pollutants.
Associations were not stronger for indoor EC
of outdoor origin compared with uncharacter-
ized EC. However, associations were stronger
for indoor PN of outdoor origin compared
with uncharacterized PN. Cu,Zn-SOD was
inversely associated with indoor OCpri of out-
door origin, whereas no associations were
found for SOA of outdoor origin.
O3. We found inverse associations of O3
with CRP, IL-6, sTNF-RII, and sP-selectin
[Supplemental Material, Table 2 (available
online at http://www.ehponline.org/members/
2008/11189/suppl.pdf)]. Conversely, O3 was
positively associated with Cu,Zn-SOD in the
27 subjects. To address the possibility that the
O3 association was spurious, we co-regressed
O3 with EC for key biomarkers [Supplemental
Material, Figure 1 (available online at http://
www.ehponline.org/members/2008/11189/
suppl.pdf)]. The associations with O3 apparent
in single pollutant models were completely
confounded by EC, whereas the associations
with EC remained stable.
Effect modification by medication use.
Biomarkers of inflammation showed differ-
ences in pollutant associations by statin use
(p < 0.1). Among 13 subjects not on statins,
CRP was more strongly associated with 3-day
and 5-day averages of markers of primary
combustion and with 7- and 9-day averages
of PN. For example, among subjects not on
statins, an interquartile increase in outdoor
3-day average EC was associated with an
increase in CRP of 1,139 ng/mL (95% CI,
168 to 2,110), whereas there was no associa-
tion among 16 subjects on statins (–45; 95%
CI, –436 to 343) (interaction p < 0.03).
There were also signiﬁcantly stronger positive
associations of CRP with outdoor PM0.25
among subjects not on statins. We found the
same trend for IL-6 with PM0.25 and longer-
term averages of markers of primary combus-
tion (7- and 9-day averages). We found
similar differences for sTNF-RII, PM mass
(especially PM0.25), and markers of primary
combustion, but with more averaging times
from lag day 0 through 9-day averages
[Supplemental Material, Figures 2 and 3
(available online at http://www.ehponline.
org/members/2008/11189/suppl.pdf)].
An opposite pattern was found for
sP-selectin. For example, among subjects on
statins, an interquartile increase in outdoor
5-day average OCpri was associated with an
increase in sP-selectin of 13.4 pg/mL (95% CI,
Delfino et al.
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Figure 1. Relationships of biomarkers of inﬂammation to outdoor air pollutants (adjusted coefﬁcient and 95% CI). (A) CRP (ng/mL). (B) IL-6 (pg/mL). (C) sTNF-RII
(pg/mL). Expected change in the biomarker corresponds to an interquartile range change in the air pollutant (Table 3). Abbreviations: ave, average; Est coef,
estimated coefﬁcient.
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200 400 6006.2 to 20.6), whereas there was no association
among subjects not on statins (–0.7; 95% CI,
–3.2 to 1.8) (interaction p < 0.0005).
We also discovered significantly weaker
associations of lag 0 through 5-day average
EC and OCpri with sP-selectin among 10
subjects taking the platelet aggregation
inhibitor clopidogrel (3 also on coumadin)
and among 16 subjects taking aspirin (4 also
on clopidogrel). These medications did not
confound pollutant interactions with statins
in relation to sP-selectin. There was little to
no evidence of differences in associations by
ACE inhibitor or ARB use.
Discussion
Primary and secondary PM and particle size
fraction. In a susceptible population of elderly
individuals with CAD, we found positive asso-
ciations of PM air pollution with biomarkers
of systemic inflammation (CRP, IL-6, and
sTNF-RII) and platelet activation (sP-
selectin). These associations were observed pri-
marily for markers of primary combustion
sources (EC, BC, and OCpri) and were associ-
ated with exposures ranging from the current
day to cumulative exposures 9 days in the past.
We also observed inverse associations of enzy-
matic antioxidant activity (Cu,Zn-SOD) with
PM for these exposures. We found some evi-
dence for stronger biomarker associations for
subjects not on statins. To our knowledge, the
present analysis is among the ﬁrst to estimate
epidemiologic associations of cardiovascular
outcomes with OC divided into two charac-
teristics representing primary and secondary
sources. This early finding is important
because little is currently known about the
pollutant components behind associations of
cardiovascular hospitalization and mortality
with ambient PM mass concentrations (Pope
and Dockery 2006). Local primary combus-
tion sources of air pollution are primarily from
mobile sources in the Los Angeles area, and
they generate high concentrations of redox-
active organic components and metals (Cho
et al. 2005; Ning et al. 2007; Ntziachristos
et al. 2007).
Air pollutants from these sources readily
penetrate into the indoor environment. This
is the first study to our knowledge showing
that associations of systemic biomarkers with
outdoor PM are consistent with associations
for indoor exposures to PM of outdoor ori-
gin, which in many (but not all) cases were
stronger than the uncharacterized indoor
exposures (EC, total OC, and PN). Results
suggest that outdoor home measurements are
sufﬁcient to capture the cardiovascular health
impacts of outdoor air pollutants even though
people spend most of their time indoors.
However, this does not apply to all outdoor
pollutants. We found that “protective” effects
of O3 were completely confounded by mark-
ers of primary combustion. This is attribut-
able partly to O3 exposure error, given that
little O3 remains stable indoors, leading to
low indoor-to-outdoor ratios, especially with
air conditioning use (Lee et al. 1999), which
was frequent during hotter periods in our
study communities.
We also found that PN (which is domi-
nated by UFPs) and outdoor PM0.25 concen-
trations were more strongly and positively
associated with biomarkers of inflammation
(CRP, IL-6, sTNF-RII) than was PM0.25–2.5,
supporting hypotheses regarding the pro-
inﬂammatory potential of UFPs (Delﬁno et al.
Biomarkers of systemic inflammation and air pollution
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Figure 2. Relationships of biomarkers of inﬂammation to indoor air pollutants (adjusted coefﬁcient and 95% CI). (A) CRP (ng/mL). (B) IL-6 (pg/mL). (C) sTNF-RII
(pg/mL). Abbreviations: ave, average; Est coef, estimated coefficient; o_o, indoor concentrations of outdoor origin. Expected change in the biomarker cor-
responds to an interquartile range change in the air pollutant (Table 3).
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200 400 600 8002005). This may be attributable partly to the
ability of UFPs to translocate systemically from
pulmonary sites (Elder and Oberdörster 2006)
and the potential of UFPs to promote oxida-
tive stress (Cho et al. 2005; Li et al. 2003).
When concentrations of PM0.25 and PM0.25–2.5
were combined to yield the typical ﬁne particle
mass metric of PM2.5, there was no evidence of
associations with CRP, IL-6, or sTNF-RII (not
shown). We also found signiﬁcant associations
of sTNF-RII, sP-selectin, and Cu,Zn-SOD
with coarse particles (PM2.5–10). In the Los
Angeles region, traffic contributes more to
UFPs and coarse PM (due to brake abrasion
and road dust resuspension) than it does to
accumulation-mode particles (Sardar et al.
2005). This is consistent with the much
stronger correlation of outdoor UFPs with
coarse PM (r = 0.83) than with accumulation-
mode PM (r = 0.44) [Supplemental Material,
Table 1 (available online at http://www.
ehponline.org/members/2008/11189/
suppl.pdf)]. PM size fractions < 0.25 and > 2.5
µm are more short-lived in ambient air. Freshly
generated reactive chemicals and transition
metals on the particle surfaces of these two size
fractions may explain the biologic responses we
observed. Our SOA results are consistent with
this hypothesis. SOA represent aerosols that are
more aged and thus have a different chemical
composition than do freshly generated
aerosols. Because we do not have detailed
chemical speciation for these particles (this is
planned for the near future), we can only
speculate on their relevance to effects.
We found evidence that PM0.25–2.5 was
associated with increased sP-selectin and
decreased Cu,Zn-SOD. However, inverse
associations of PM0.25–2.5 and secondary OC
with IL-6 and CRP are unexplained. They are
not explained by interpollutant correlations
between the markers of primary combustion
and SOA or PM0.25–2.5, which were are all
positive, albeit small. The lack of associations
or weakened associations for indoor particle
mass (especially for CRP, IL-6, and sTNF-
RII) may be attributable to contributions
from indoor sources such as cooking.
Comparison with the literature. Our
results for markers of primary combustion in
the outdoor home environment point to the
importance of trafﬁc-related sources of pollu-
tants. This is supported by a previous study
showing that emergency department visits for
acute myocardial infarction were associated
with reports of in-vehicle exposures during the
hours preceding symptom onset (Peters et al.
2004). Our results are also generally consistent
with other recent longitudinal studies with
repeated measures that have shown elevated
ambient PM concentrations are associated
with increased levels of circulating biomarkers
of inﬂammation, although not always for the
same sets of biomarkers (Chuang et al. 2007;
Dubowsky et al. 2006; Rückerl et al. 2006,
2007a, 2007b; Yue et al. 2007). Our null
ﬁnding for ﬁbrin D-dimer is consistent with
two other air pollution studies (Rückerl et al.
2006; Sullivan et al. 2007). In a panel study of
subjects who had survived myocardial infarc-
tion, Rückerl et al. (2007a) found signiﬁcant
positive associations of IL-6 with central-site
PN measurements, and ﬁbrinogen with 5-day
average PM10, but no signiﬁcant associations
with CRP. We found associations of PM0.25
with CRP but not fibrinogen. Ambient PM
has been inconsistently associated with
fibrinogen and CRP in various studies as
discussed in Rückerl et al. (2007a).
Data are more scarce for sTNF-RII (Cox
et al. 1999). sTNF-RII can compete with the
membrane-bound forms of the TNF receptor
and thus reduce TNF-dependent cell signaling
(Heaney and Golde 1998). Signiﬁcant positive
associations with sTNF-RII and positive (but
largely nonsigniﬁcant) coefﬁcients for TNF-α
point to an up-regulated inflammatory
response to PM. This difference in signifi-
cance for the receptor and cytokine may be
attributable to the longer half-life and higher
levels of the soluble receptor than of TNF-α
in plasma. Additional data are needed to test
the importance of sTNF-RII as a biomarker of
the proinﬂammatory effects of air pollutants.
Our ﬁndings for sP-selectin suggest that air
pollutants can induce platelet activation, which
is supported by human experimental data
(Törnqvist et al. 2007). P-selectin is critical for
initial leukocyte adhesion to platelets and
endothelial cells, and activates leukocytes and
endothelial cells at sites of arterial injury (Jurk
and Kehrel 2005). Clinical studies have shown
that clopidogrel is associated with decreased sP-
selectin (Xiao and Théroux 2004), which may
explain our ﬁnding smaller magnitudes of asso-
ciation between air pollutants and sP-selectin
in subjects taking clopidogrel. A similar panel
study of 57 men with CAD showed central-site
ultrafine PN concentrations in Erfurt,
Germany, was positively associated with solu-
ble CD40 ligand, another marker of platelet
activation (Rückerl et al. 2007b).
Antioxidant activity. A novel ﬁnding is the
inverse associations of exposure to primary
Delfino et al.
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Figure 3. Relationship of sP-selectin to outdoor and indoor air pollutants (adjusted coefﬁcient and 95% CI).
(A) Outdoor air pollutants. (B) Indoor air pollutants. Abbreviations: ave, average; Est coef, estimated coefﬁ-
cient; o_o, indoor concentrations of outdoor origin. Expected change in sP-selectin (ng/mL) corresponds
to an interquartile range change in the air pollutant (Table 3). 
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4 8 12 16combustion aerosols with the antioxidant
erythrocyte enzyme Cu,Zn-SOD (Figure 4)
and, to a less significant extent, GPx-1
[Supplemental Material, Tables 2–4 (available
online at http://www.ehponline.org/members/
2008/11189/suppl.pdf)]. We initially hypothe-
sized that antioxidant activity would increase in
response to exposure (this was the case in three
subjects). Diminished antioxidant response
could lead to oxidative stress and then inﬂam-
mation, with increased susceptibility to adverse
cardiovascular events. The potential impor-
tance of this finding is shown in prospective
cohort studies that found a low level of ery-
throcyte GPx-1 activity was associated with
increased risk of nonfatal myocardial infarction
or death from cardiovascular causes in patients
with CAD (Espinola-Klein et al. 2007).
Erythrocytes account for much of the
antioxidant capacity of the blood and are
packed with enzymes that handle intracellular
oxidative stress from the continuous endoge-
nous generation of oxygen radicals (Tsantes
et al. 2006). Pollutant-induced increases in
oxidative or nitrosative stress throughout the
circulation could overburden erythrocytic
antioxidant defense. An in vitro study using
pulmonary macrophages and erythrocytes
showed that UFPs enter these cells by diffu-
sion or adhesive interactions, and particles
within cells were not membrane bound,
thereby having direct access to intracellular
proteins (Geiser et al. 2005). Other data show
that PAHs can be transferred from the UFP
surface to the cell membrane and then cross
the membrane into the cytosol (Penn et al.
2005). UFPs and their redox cycling pollu-
tant components could thus induce oxidative
stress as shown with macrophage and epithe-
lial cell cultures (Li et al. 2003).
Our finding of reduced activity of ery-
throcyte Cu,Zn-SOD and GPx-1 may be
partly a consequence of enzyme inactivation
by free radicals (Pigeolet et al. 1990). This
could occur through oxidative modification
of amino acids or irreversible modiﬁcation of
enzyme function by electrophiles (Shinyashiki
et al. 2008). In vitro data using enzyme sus-
pensions have shown marked reduction in the
activity of GPx-1, Cu,Zn-SOD, and/or man-
ganese SOD from variety of particle surro-
gates (Hatzis et al. 2006). GPx-1 and
Cu,Zn-SOD activities decreased in the lungs
of rats following intratracheal instillation of
diesel exhaust particles (Sagai et al. 1993).
Strengths and limitations. The primary
strength of our findings is that we measured
exposures in the microenvironments where
subjects spend most of their time, and we
designed the measurements to identify causal
pollutant characteristics, which cannot be
inferred from regulated particle mass (PM2.5
or PM10) from regional monitoring stations.
The calculation of OCpri and secondary OC
combined with an estimation of indoor expo-
sure to PM of outdoor origin provided among
the first data showing associations between
indoor urban particle components and sys-
temic biomarkers in free-living humans. This
addresses a critical weakness in the use of cen-
tral regional data in that it does not capture
the high spatial variability of pollutants from
proximity to sources of primary combustion
gases and aerosols, which include UFPs and
their associated high concentrations of redox
active components (Ntziachristos et al. 2007).
Another year of data collection and analysis is
planned (62 total subjects), and we anticipate
that this will strengthen the present ﬁndings.
Our study also has several limitations.
Although the data were collected in the home
environment of subjects, we were not able to
correct for exposures in other environments,
which is usually accomplished with personal
air monitors. In addition, we could perform
only a limited assessment of differences in
association based on clinical characteristics,
but we anticipate sufficient power to do so
with a planned doubling of sample size.
We tested multiple outcomes and expo-
sures, potentially increasing the probability of
a type 1 error. However, this was not an
exploratory study without any prior knowl-
edge or hypotheses; thus, corrections such as
Bonferroni are inappropriate. Furthermore,
the strong dependence among the air pollu-
tants and among the biomarkers argues
against correction of multiple testing by the
number of tests (Bender and Lange 2001).
We selected the biomarkers and exposure
measurements to represent parts of key bio-
logic pathways and pollutant characteristics,
respectively, that were representative of our
hypotheses. However, it is likely that the bio-
markers are not all equivalent in their sensitiv-
ity to pollutant-induced responses and that
the exposures are not all equivalent in their
representation of causal pollutant compo-
nents. In this sense, the exploratory nature of
the research is to provide data for the selec-
tion of the best biomarkers (e.g., IL-6,
sP-selectin) and exposures (e.g., EC or BC)
for future research. The challenge will be to
evaluate the impacts of air pollution on the
Biomarkers of systemic inflammation and air pollution
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Figure 4. Relationship of Cu,Zn-SOD to outdoor and indoor air pollutants (adjusted coefﬁcient and 95% CI).
(A) Outdoor air pollutants. (B) Indoor air pollutants. o_o, indoor concentrations of outdoor origin; Est Coef,
estimated coefficient. Expected change in Cu,Zn-SOD (U/g Hb) corresponds to an interquartile range
change in the air pollutant (Table 3).
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–400 –200 200 400 600inflammatory cascade of events that begins
with oxidative stress and may end with
thrombosis (two phenomena that we did not
adequately characterize here).
Conclusions
Our results suggest that traffic-related emis-
sion sources of PM2.5 OCpri, and UFPs lead to
increases in systemic inflammation, platelet
activation, and decreases in erythrocyte antiox-
idant activity in elderly people with a history
of CAD. This is strongly supported by our
ﬁndings of generally more robust associations
for indoor PM of outdoor origin (PN concen-
tration, PM2.5 OCpri, and EC), particularly
given that people spend most of their time
indoors. We found little to no evidence for
associations with secondary PM2.5 OC or total
OC, perhaps because the biologic responses
we observed were triggered by freshly gener-
ated reactive chemicals on particle surfaces.
UFPs are particularly enriched with redox-
active chemicals. This is important because
oxidative stress may be a mechanism whereby
air pollutants induce inﬂammation in the air-
ways and systemically, leading to acute
adverse cardiorespiratory responses. The
increase in oxidative (or nitrosative) stress can
occur through pollutant-induced increases in
reactive oxygen (or nitrogen) species com-
bined with decreases in antioxidant enzyme
activity (as we have shown). Diminished
enzymatic antioxidant activity in erythrocytes
could reflect increased plasma oxidative/
nitrosative demands, which results in systemic
inflammation as indicated in our study by
CRP, sTNF-RII, IL-6, and sP-selectin. The
public health relevance of our ﬁndings is that
they come from the everyday life of a suscep-
tible population living in a large U.S. city
with infrequent violations of U.S. National
Ambient Air Quality Standards during the
study (South Coast Air Quality Management
District 2007).
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